Associate professor Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- Room
- J8-29
- redekop@eshpm.eur.nl
‹ Back to overview
Profile
Ken Redekop, Ph.D. is an associate professor at the Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, The Netherlands. He is a clinical epidemiologist with more than 20 years of experience in observational research, clinical trial analysis, and medical technology assessment and an author of over 100 papers in the medical literature. Current studies include early-stage cost-effectiveness analyses of medical devices and tests, RCT-based economic evaluations, economic evaluations in the Diagnostics Assessment programme of the National Institute for Health and Clinical Excellence (NICE, UK) and outcomes research studies to determine the effectiveness and cost-effectiveness of expensive medicines in daily practice. Most studies relate to diabetes, cardiovascular disease, and cancer, and most involve modelling and evidence synthesis.
- Remziye Zaim, Ken Redekop & C.A. (Carin) Uyl - de Groot (2022) - Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer - Translational Oncology, 20 - doi: 10.1016/j.tranon.2022.101418 - [link]
- Sara Landerdahl Stridsberg, Matt X. Richardson, Ken Redekop, Maria Ehn & Sarah Wamala Andersson (2022) - Gray Literature in Evaluating Effectiveness in Digital Health and Health and Welfare Technology: A Source Worth Considering - Journal of Medical Internet Research, 24 (3), e29307 - doi: 10.2196/29307 - [link]
- Feline F.J.A.Ter Bruggen, W. Ken Redekop, Dirk L. Stronks & Frank J.P.M. Huygen (2021) - Long-term effects of dexmedetomidine versus propofol during the implantation of a neurostimulator—a post-trial follow-up analysis - Journal of Pain Research, 14, 3631-3636 - doi: 10.2147/JPR.S323961 - [link]
- L. A. Visser, S. P.I. Huls, C. A. Uyl-de Groot, E. W. de Bekker-Grob & W. K. Redekop (2021) - An implantable device to treat multiple sclerosis: A discrete choice experiment on patient preferences in three European countries - Journal of the Neurological Sciences, 428 - doi: 10.1016/j.jns.2021.117587 - [link]
- Laurenske A. Visser, Marc Folcher, Claudia Delgado Simao, Biotza Gutierrez Arechederra, Encarna Escudero, Carin A. Uyl-de Groot & William Ken Redekop (2021) - The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis - PharmacoEconomics, 40 (1), 91-108 - doi: 10.1007/s40273-021-01081-y - [link]
- Lytske J. Bakker, Lucas M.A. Goossens, Maurice J. O'Kane, Carin A. Uyl-de Groot & William K. Redekop (2021) - Analysing electronic health records: The benefits of target trial emulation - Health Policy and Technology, 10 (3) - doi: 10.1016/j.hlpt.2021.100545 - [link]
- Ana Dubon Garcia, Roland Devlieger, WK (Ken) Redekop, Katleen Vandeweyer, Stefan Verlohren & Liona C. Poon (2021) - Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium - Pregnancy Hypertension, 25, 219-224 - doi: 10.1016/j.preghy.2021.06.012 - [link]
- WK (Ken) Redekop & Donald RJ Singer (2021) - Conference to mark the 10<sup>th</sup> anniversary for the Health Policy and Technology journal - Health Policy and Technology, 10 (2) - doi: 10.1016/j.hlpt.2021.100540 - [link]
- Laurenske Visser, Marleen de Mul & Ken Redekop (2021) - Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis:: A Focus Group Study to Examine Patient Perspectives - Patient Preference and Adherence, 15, 927-937 - doi: 10.2147/PPA.S306132 - [link]
- Laurenske A. Visser, Celine Louapre, Carin A. Uyl-de Groot & WK (Ken) Redekop (2021) - Health-related quality of life of multiple sclerosis patients: a European multi-country study - Archives of Public Health, 79 (1) - doi: 10.1186/s13690-021-00561-z - [link]
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
Master Thesis Eu-HEM
- Level
- master
- Year
- 2022
- Year Level
- master
- Course Code
- GW4560M
Afstudeerproject
- Level
- bachelor 3
- Year
- 2022
- Year Level
- bachelor 3
- Course Code
- GW310
Master Thesis HE
- Year
- 2022
- Year Level
- master, master
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year
- 2022
- Year Level
- master
- Course Code
- GW4555M
Module Knowledge
- Level
- bachelor 2
- Year
- 2022
- Year Level
- bachelor 2
- Course Code
- GW205K
Integration project
- Level
- bachelor 2
- Year
- 2022
- Year Level
- bachelor 2
- Course Code
- GW205I
Academic Development & Skills
- Level
- bachelor 2
- Year
- 2022
- Year Level
- bachelor 2
- Course Code
- GW205AVV